BioRestorative Therapies and Cartessa Strike Groundbreaking Deal to Revolutionize Medical Aesthetics

BioRestorative Therapies, a pioneer in life sciences specializing in stem cell therapies, has recently unveiled a significant commercial agreement with Cartessa, a global frontrunner in the field of medical aesthetics technology. This strategic partnership is set to transform the landscape of aesthetic treatments by integrating cutting-edge stem cell technologies into mainstream cosmetic procedures. Under this […]
Innovative Breakthrough: BioRestorative Therapies Secures Key Patent for Obesity Treatment Program

BioRestorative Therapies, Inc., a pioneering clinical-stage company specializing in stem cell-based therapies, has achieved a significant milestone in its quest to combat obesity and metabolic disorders. The United States Patent and Trademark Office has issued a notice of allowance for a patent application related to the company’s ThermoStem® program. This development, announced on December 12, […]
BioRestorative Therapies Announces SBIR Phase I Grant to Explore the Therapeutic Effects of ThermoStem® Targeting Polycystic Ovary Syndrome as an Indication

MELVILLE, N.Y., Dec. 06, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced that it has been awarded a Small Business Innovation Research (SBIR) Phase I grant from the Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the […]